Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Change in Cash (2016 - 2025)

Historic Change in Cash for Option Care Health (OPCH) over the last 15 years, with Q3 2025 value amounting to $111.0 million.

  • Option Care Health's Change in Cash rose 456.88% to $111.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$173.2 million, marking a year-over-year decrease of 27941.72%. This contributed to the annual value of $68.7 million for FY2024, which is 3836.46% up from last year.
  • Per Option Care Health's latest filing, its Change in Cash stood at $111.0 million for Q3 2025, which was up 456.88% from $27.4 million recorded in Q2 2025.
  • Option Care Health's Change in Cash's 5-year high stood at $157.4 million during Q2 2024, with a 5-year trough of -$241.2 million in Q1 2025.
  • In the last 5 years, Option Care Health's Change in Cash had a median value of $27.4 million in 2025 and averaged $11.1 million.
  • The largest annual percentage gain for Option Care Health's Change in Cash in the last 5 years was 29414.74% (2024), contrasted with its biggest fall of 356339.83% (2024).
  • Over the past 5 years, Option Care Health's Change in Cash (Quarter) stood at -$81.4 million in 2021, then surged by 147.55% to $38.7 million in 2022, then crashed by 210.13% to -$42.6 million in 2023, then plummeted by 65.25% to -$70.5 million in 2024, then skyrocketed by 257.54% to $111.0 million in 2025.
  • Its Change in Cash was $111.0 million in Q3 2025, compared to $27.4 million in Q2 2025 and -$241.2 million in Q1 2025.